주 메뉴 바로가기 본문 바로가기 하단 바로가기
01_3.jpg

Celltrion Healthcare

We have been contributing to the improvement of patient welfare and access to health care by offering innovative biologics to the world.

CTHC-UK-182 July 2020

BUSINESSWe are exerting efforts to achieve sustainable growth.

Celltrion Healthcare will shape a healthier and happier future for humanity by offering high-quality biologics.

Celltrion Healthcare offers biologics to about 85 countries, along with more than 34 global partners around the world. With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets of the United States and Europe, Celltrion Healthcare has been securing distribution channels and providing patients with biosimilars at affordable prices.

CTHC-UK-184A July 2020

Core Values

Celltrion Healthcare turns "Opportunities" into "Realities".

  • 창의력의 느낌인 전구 아이콘

    CreativityCreativity
    We solve problems by going beyond our usual way of thinking and enhancing creative thinking.
  • 날리는 깃발 아이콘

    PrinciplesCompliance with Principles
    We comply with principles while maintaining confidence and trust.
  • 법원 느낌의 건물 아이콘

    InnovationThe Spirit of Challenge
    We make every effort to find new ways despite challenges.
  • 지구본 아이콘

    World BestThe Pursuit to Be the World’s Best
    We strive to be professional and competent to lead the global markets.

CTHC-UK-183D July 2020

GLOBAL NETWORKS

Global biologics
leading company

Celltrion Healthcare has become the world’s leading company that specializes in biologics by offering high-quality biosimilars to about 110 countries, with the ultimate goal of promoting the welfare of humanity.

Click here for details

CTHC-UK-184E July 2020

Cookie technology helps us bring you the best possible experience when you visit this website. If you continue without changing your settings, you are agreeing to the cookies on this website. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.